Global Bioactive Material Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
The global bioactive material market is estimated to reach $2.85 billion by 2022 and is expected to grow at CAGR of 13.8% during 2016-2022.
The bioactive material market is majorly driven by the rising demand of bioactive material in various regions. The key drivers of this market are growing cases of organs failure, increasing use of spinal and orthopedic procedures, rising use of synthetic materials in grafting process and rising ageing population. However, the Metaphyseal defect also known as autoimmune defect is the major factor which is hindering the growth of the global bioactive material market. In addition, high costs of new technologies is also hampering the growth of the global bioactive material. The global bioactive material market has large number of opportunities such as increasing cases of disease and need for advanced treatment procedures in emerging countries.
The bioactive material market is segmented on the basis of material, type, production method, application and geography. On the basis of material, the market is segmented into ceramics, glass, glass-ceramics, composites and others. Based on the type, the market is segmented into powders and nano powders, granules, monoliths, moldable and injectable products and coatings. Based on the production method, the market is segmented into seven categories such as melting, sol-gel, specialty processes for glass and glass-ceramics, milling and sintering, spray-drying, plastic processing and impregnation. Based on the application, the market is segmented into dentistry, medicine, pharmaceuticals, surgery, bioengineering and others. Bioactive materials are widely used in almost every sectors of medicine, pharmaceuticals and dentistry.
The bioactive material market is in different stages of growth in different countries. North America dominates the bioactive material market with the largest share because of large investments in healthcare sector and increasing number of minimally invasive surgeries. After North America , the demand for bioactive materials is also increasing in Asia Pacific, mainly in India, China and Japan due to increasing healthcare expenditure and disposal incomes, and increasing ageing population. As increasing ageing population results in growth of trauma and orthobiologic surgeries, it will in turn drive the global bioactive material market.
The bioactive material market is dominated by some of the major key players such as 3Di, Aap Implantate, Arthrex, Baxter, Berkeley advanced, Biomatlante, Biomet, Curasan, Integra Life Science, Dentsply, Heraeus Kulzer, Kyocera, Novabone, and many more. Innovation, agreements, collaboration, partnerships and expansion is regarded as the key strategies to have a strong hold in the market and maintain a global presence. On 20 April, 2015, Aap Implantate, a manufacturer, distributer, and developer of biomaterials and enhanced trauma products, declared that the European Patent Office newly granted it an essential patent for silver coating technology for health implants. The European patent looks after the multifunctional antibacterial silver coating manufactured by the company for implants and relevant medical tools for the invention of coating.
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.